Gordon H. Guyatt
McMaster University
1754 Papers
10.7K Citations
Gordon H. Guyatt is an academic researcher from McMaster University. The author has contributed to research in topics: Medicine & Randomized controlled trial. The author has an hindex of 231, co-authored 1620 publications. Previous affiliations of Gordon H. Guyatt include Memorial Sloan Kettering Cancer Center & Cayetano Heredia University.
Chat about Author
Papers
A practical approach to evidence-based dentistry: IV: how to use an article about harm
Romina Brignardello-Petersen,Alonso Carrasco-Labra,Michael Glick,Gordon H. Guyatt,Amir Azarpazhooh +4 more
TL;DR: Dentists who wish to inform their clinical decisions regarding questions of harm can use these guidelines to decide what type of studies to search, define the specific question of interest to search efficiently for these studies, and critically appraise an article about harm.
13
Methodology for the Guidelines on Evaluation and Management of Hypoparathyroidism and Primary Hyperparathyroidism
Liang Yao,Gordon H. Guyatt,Zhikang Ye,John P. Bilezikian,Maria Luisa Brandi,Bart L. Clarke,Michael Mannstadt,Aliya Khan +7 more
TL;DR: The methodology for issuing GRADEd and non-GRADEd recommendations for patients with hypoparathyroidism or hyperparathyroidistan is summarised.
12
Sources of bias in diagnostic accuracy studies and the diagnostic process.
TL;DR: The fundamental design of studies assessing the accuracy of diagnostic tests involves a comparison of studies that purport to establish those performance characteristics of the tests used.
Addition of Ezetimibe to statins for patients at high cardiovascular risk: Systematic review of patient‐important outcomes
Yutong Fei,Yutong Fei,Gordon H. Guyatt,Paul E. Alexander,Regina El Dib,Regina El Dib,Reed A C Siemieniuk,Per Olav Vandvik,Mark E. Nunnally,Huda Gomaa,Rebecca L. Morgan,Arnav Agarwal,Arnav Agarwal,Ying Zhang,Neera Bhatnagar,Frederick A. Spencer +15 more
TL;DR: The analysis of the IMPROVE-IT study results showed that in patients at high risk of cardiovascular events, ezetimibe added to statins was associated with a likely reduction in non-fatal MI but is unlikely to reduce all-cause mortality or cardiovascular death.
12
Patient Values and Preferences Regarding Continuous Subcutaneous Insulin Infusion and Artificial Pancreas in Adults with Type 1 Diabetes: A Systematic Review of Quantitative and Qualitative Data.
Oscar Mauricio Muñoz-Velandia,Gordon H. Guyatt,Tahira Devji,Yuan Zhang,Shelly-Anne Li,Paul E. Alexander,Diana Henao,Ana-María Gomez,Álvaro Ruiz-Morales +8 more
TL;DR: Clinician guidance may play a crucial role in determining patient values and preferences (for instance, patients' priority in glucose control rather than avoiding diabetic complications) and the results provide guidance in discussing preferred insulin delivery systems with patients with type 1 diabetes.
12